2006
DOI: 10.4049/jimmunol.176.4.2346
|View full text |Cite
|
Sign up to set email alerts
|

CCL5 Modulates Pneumococcal Immunity and Carriage

Abstract: Understanding the requirements for protection against pneumococcal carriage and pneumonia will greatly benefit efforts in controlling these diseases. Recently, it has been shown that genetic polymorphisms can result in diminished expression of CCL5, which results in increased susceptibility to and progression of infectious diseases. We show that CCL5, together with Th cytokine mRNA expression, is temporally up-regulated during pneumococcal carriage. To determine the contribution of CCL5 to pneumococcal surface… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
39
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(41 citation statements)
references
References 65 publications
2
39
0
Order By: Relevance
“…Our data indicate that the type I IFNs produced by pneumococciinfected macrophages affect macrophages and neighboring AECs in an autocrine and paracrine manner, leading to an enhanced production of RANTES, which is involved in the host defense to pneumococcal pneumonia (54). We speculate that IFN a/b released by S. pneumoniae-infected macrophages binds to IFNAR and activates STAT transcription factors, which in turn enhance transcription of the RANTES promoter (56).…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…Our data indicate that the type I IFNs produced by pneumococciinfected macrophages affect macrophages and neighboring AECs in an autocrine and paracrine manner, leading to an enhanced production of RANTES, which is involved in the host defense to pneumococcal pneumonia (54). We speculate that IFN a/b released by S. pneumoniae-infected macrophages binds to IFNAR and activates STAT transcription factors, which in turn enhance transcription of the RANTES promoter (56).…”
Section: Discussionmentioning
confidence: 93%
“…RANTES is a key chemokine involved in the host defense to pneumococcal pneumonia (54). We infected BMMs from wt or IFNAR-deficient mice with S. pneumoniae D39.…”
Section: Sting and Irf3 Mediate Ifn-b Production In S Pneumoniaeinfementioning
confidence: 99%
“…In our subjects with AUDs, RANTES levels correlated with levels of IP-10, a CXC chemokine secreted by cells in response to IFN-␥. In the setting of experimental pneumococcal pneumonia, pulmonary levels of RANTES and IP-10 may be increased (21,40) and, along with other proinflammatory cytokines, appear to play a role in the pneumococcal immune response. In animal experiments using an EF3030 pneumococcal strain, RANTES also influenced the production of antibodies that limited the progression of nasopharyngeal pneumococcal carriage to frank pneumonia and influenced survival (40).…”
Section: Discussionmentioning
confidence: 99%
“…In the setting of experimental pneumococcal pneumonia, pulmonary levels of RANTES and IP-10 may be increased (21,40) and, along with other proinflammatory cytokines, appear to play a role in the pneumococcal immune response. In animal experiments using an EF3030 pneumococcal strain, RANTES also influenced the production of antibodies that limited the progression of nasopharyngeal pneumococcal carriage to frank pneumonia and influenced survival (40). Our observation that BAL RANTES was increased in a dosedependent fashion among subjects with AUDs suggests a potential protective role of alcohol in pneumococcal infection.…”
Section: Discussionmentioning
confidence: 99%
“…002D5 was cultured in ToddHewitt broth with 17% fetal calf serum to mid-logarithmic phase, snapfrozen in liquid nitrogen, and stored at Ϫ70°C (24). Viability of the inoculum was checked by counting colonies from serial dilutions plated on blood agar, which remained stable for at least 1 year.…”
Section: Methodsmentioning
confidence: 99%